IRVINE, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives ...
IRVINE, Calif., May 21, 2018 /PRNewswire/ -- Inari Medical, Inc., announced today the FlowTriever System has received FDA 510(k) clearance for the treatment of pulmonary embolism ("PE"). This ...
IRVINE, Calif., April 27, 2018 /PRNewswire/ -- Inari Medical, Inc., announced today the presentation of results from its FlowTriever Pulmonary Embolectomy ("FLARE") Clinical Study that evaluated the ...
Irvine Calif.-based Inari Medical Inc. reported results from what it described as the largest prospective study of interventional treatment in high-risk pulmonary embolism (PE), which found a 90% ...
IRVINE, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the ...
For patients with intermediate- or high-risk pulmonary embolism (PE), removing the blockage with the FlowTriever percutaneous mechanical thrombectomy system (Inari Medical) is both safe and effective, ...
IRVINE, Calif., March 06, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results